Nicotinamide adenine dinucleotide, or NAD+, has become a hot topic in the wellness and longevity world. Clinics, influencers and some celebrities promote pills, injections and IV drips that claim to boost energy, reverse aging, speed recovery and improve mental clarity. Scientists who study NAD+ say the underlying biology is compelling, but the clinical evidence in people is still limited and mixed.
What NAD+ does
NAD+ is a central cellular molecule involved in energy production, mitochondrial function and DNA repair. Levels of NAD+ decline with age, and researchers hypothesize that restoring or increasing NAD+ could help prevent or treat age-related decline and disease. That idea is scientifically attractive, and it has driven a lot of preclinical research.
What the lab and animal studies show
In mice and other animal models, raising NAD+ levels often produces striking benefits: improved mitochondrial health, better strength and exercise capacity, reduced metabolic dysfunction and lower inflammation. Those results are the main reason for the excitement among researchers and the public. But animal results do not always translate to humans.
Human trials so far
Most human studies have tested NAD+ precursors rather than NAD+ itself. Two common precursors are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Small clinical trials have shown promising signals in certain groups — for example, people with prediabetes, some patients with Parkinson’s disease and people with peripheral artery disease. Other trials, particularly in metabolic health, have not reproduced the robust effects seen in animals.
Researchers have also shown that taking NR or NMN can raise blood NAD+ levels after several weeks, but whether that reliably produces meaningful health outcomes in broad populations is not yet established. Large, long-term randomized trials are still needed.
The products on the market
The marketplace is wide and often confusing. Companies sell direct NAD+ pills, NR and NMN supplements, injections and IV infusions. Scientists note a couple of practical issues:
– Oral NAD+ itself is likely degraded in the gut and poorly absorbed, which is why most researchers study precursors like NR and NMN.
– NAD+ infusions and injections are being marketed widely, but there is little published evidence showing they effectively increase NAD+ inside cells. Preliminary work suggests direct NAD+ in the bloodstream has a hard time entering cells.
– Prices vary greatly: over-the-counter precursor pills can run from about $30 to $80 or more, injections cost hundreds, and IV drip sessions can be $200 to $1,000 or higher.
Safety and quality concerns
Available clinical trials suggest NR and NMN are generally well tolerated in the short term, and researchers describe the safety data as reassuring so far. However, long-term risks remain unknown because multi-year human trials are lacking. Some animal studies raised theoretical concerns that boosting NAD+ might influence tumor growth in certain contexts, but this has not been widely observed in animals or humans.
Independent testing of supplements has revealed variability in product quality and inconsistencies between labels and actual contents. That makes choosing reputable products important if someone decides to try supplements.
Reports about NAD+ infusions note mixed findings on safety and tolerance. Small pilot studies indicate infusions may be inefficient at raising intracellular NAD+ and, in some participants, can cause unpleasant gastrointestinal symptoms such as abdominal cramping, nausea, vomiting and diarrhea.
Expert perspective
Many scientists involved in NAD+ research emphasize that the hypothesis is promising and that rigorous studies are underway. But several warn that the current consumer market is ahead of the science. Influencer-driven demand and commercial offerings can complicate careful clinical research and lead to widespread use before benefits and risks are clearly defined.
Bottom line
NAD+ biology is fascinating and animal data are encouraging, but the evidence that NAD+ supplements, shots or IV infusions improve health or increase longevity for most people is not yet established. Precursors like NR and NMN can raise blood NAD+ and appear safe in the short term, but benefits shown so far are limited to small or specific-study populations and have not been consistently replicated.
If you are considering NAD+ products, talk with your clinician. Ask about the type of product (precursor versus NAD+), the quality and testing of the supplement, potential side effects, and whether there is any clinical reason to try it for your situation. For now, large, well-controlled human trials are needed to determine whether boosting NAD+ will deliver the broad anti-aging or health benefits claimed by some marketers.